Search
  • Within this site
AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
Back to search results

Human Catechol-O-Methyltransferase (Comt) Assay


Summary

Disclosed Is An Assay (Method) To Quantify The Amounts Of Catecholamine-O-Methyltransferase (Comt) Protein In Samples, Such As Extracts From Cell Cultures, Body Fluids, Tissues, And Environmental Samples. It Uses Novel Agents (Anti-Ne, Comt-Ne, Or Comt-Epitope-Ne) In Combination With Two Previously Described Agents (Anti-Comt And Comt) In A Competitive Elisa System To Achieve This Aim.


Supplementary Information

Patent Number: US8927225B2
Application Number: US2009555529A
Inventor: Ho, Shu Leong | Ho, Wing Lok | Ramsden, David Boyer
Priority Date: 26 Sep 2008
Priority Number: US8927225B2
Application Date: 8 Sep 2009
Publication Date: 6 Jan 2015
IPC Current: C07K000708 | C07K001640 | C07K001644 | C12N000910 | G01N0033535 | G01N0033543 | G01N0033573
US Class: 4350074 | 43500793 | 43500794 | 43500795 | 435015 | 4350693 | 4350697 | 435975 | 436501 | 436518 | 436528 | 436547 | 436548 | 530300 | 530324 | 530326 | 530350 | 5303879 | 53038826 | 5303891 | 5303911 | 5303913 | 530403
Assignee Applicant: The University of Hong Kong
Title: Human catechol-O-methyltransferase (COMT) assay
Usefulness: Human catechol-O-methyltransferase (COMT) assay
Summary: The isolated polypeptide or the antibody is useful for the manufacture of the kit for detection of COMT in a sample (claimed).
Novelty: New isolated polypeptide comprises novel-epitope (NE)-epitope or a variant of NE-epitope that binds with antibody to NE-epitope, useful for manufacturing a kit for detecting catechol-O-methyltransferase (COMT) in a sample


Industry

Chemical/Material


Sub Group

Chemical Composition


Application No.

US2009555529A


Country/Region

Hong Kong

For more information, please click Here
Business of IP Asia Forum
Desktop View